and cancer are complex diseases, which involve multiple genetic and environmental factors as well as complicated interactions among those factors. Previously, JMCB published several issues exploring complex diseases from various perspectives (Chen and Wu, 2012; Wu, 2012 Wu, , 2013 Wu, , 2016 . Research articles in the current issue report molecular factors or mechanisms that were recently found to be involved in various complex diseases, which might provide new candidates for biomarkers or drug targets against these complex diseases.
It is known that the expression level of glycogen synthase kinase 3β (GSK3β) is upregulated in polycystic kidney disease (PKD). In the first article of this issue, Dr Rao's laboratory uncovered the mechanism for regulation of GSK3β expression in PKD. The authors found that increases in renal GSK3β expression were coincident with increases in renal cAMP levels during PKD progression in mouse models, and GSK3β was a cAMP-responsive gene that could be elevated by increased cAMP levels both in vivo and in vitro. They further showed that this regulation was part of a feed-forward loop, in which cAMP through CREB regulated GSK3β expression, and GSK3β in turn positively regulated cAMP generation.
Mesangioproliferative glomerulonephritis (MsPGN) is another kidney disease with high incidence in humans. By studying rat Thy-1 nephritis (Thy-1N), a well-known model of MsPGN, Dr Wang's laboratory found that sublytic C5b-9 triggered glomerular mesangial cell (GMC) apoptosis. The authors demonstrated that sublytic C5b-9 could upregulate the expressions of Egr-1, ATF3, and Gadd45, resulting in GMC apoptosis in vitro. Furthermore, the in vivo studies showed that inhibition of renal p300, Egr-1, ATF3, and Gadd45β/γ decreased GMC apoptosis in Thy-1N rats.
There are two major types of fatty liver disease: alcoholic fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD), resulting from distinct molecular and cellular mechanisms. Dr Feng and Dr Lu's laboratory reported that a signalling adaptor protein, GRB2-associated-binding protein 2 (Gab2), was involved in both AFLD and NAFLD. The authors demonstrated that Gab2 knockout mice exhibited resistance to various pathogenic stimulations, such as fat-induced obesity and alcohol-stimulated hepatic steatosis. They showed that both fat and alcohol could induce Gab2-mediated recruitment of PI3K or Socs3 in hepatocytes and then activate their downstream signalling proteins, suggesting that Gab2 plays a role in fatty liver disease development through amplifying and coordinating signals activated by various pathogenic factors.
It is known that the accumulation of proinflammatory M1 macrophages in adipose tissue is a critical event resulting in metabolic complications of obesity. In this issue, Dr Han's laboratory reported that adipocyte-derived microvesicles (ADM) could modulate macrophage phenotype in mice. The authors found that ADM from high-fat diet (HFD)induced obese mice (HFD ADM) increased the expression of M1 markers, and miR-155 was upregulated in both HDF ADM and HFD ADM-treated macrophages. They further showed that the secreted miR-155 from HFD ADM induced M1 macrophage polarization by targeting SOCS1 and activating JAK/STAT pathway. Importantly, miR-155-polarized macrophages reciprocally regulated insulin signalling and glucose uptake in adipocytes, resulting in chronic inflammation and insulin resistance.
